Orchid Pharma gets ANDA nod from USFDA for Risedronate Sodium tablets

Orchid Pharma has received ANDA approval from USFDA for Risedronate Sodium Tablets USP, 30 mg and 35 mg.

from India Infoline News Service http://bit.ly/2VW6zZF